Clinical Trial Update: Continuation of First-line Therapy With Radiotherapy Versus Early Switch to Second-line Therapy in Oligoprogressive HCC [Phase 3]

View source ↗

Summary

This entry describes a Phase 3 trial comparing continuation of first-line radiotherapy versus early switch to second-line therapy for oligoprogressive hepatocel…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Snippet

Sponsor: Shandong Cancer Hospital and Institute | Conditions: OligoProgressive Metastatic Disease, Hepatocellular Carcinoma (HCC) | Phase 3 | Status: RECRUITING